H. Headon, U. Wazir, A. Kasem, and K. Mokbel, Surgical treatment of the primary tumour improves the overall survival in patients with metastatic breast cancer: A systematic review and meta-analysis, Molecular and Clinical Oncology, vol.4, issue.5, pp.863-867, 2016.
DOI : 10.3892/mco.2016.778

E. Bertani, N. Fazio, and D. Radice, Assessing the role of primary tumour resection in patients with synchronous unresectable liver metastases from pancreatic neuroendocrine tumour of the body and tail. A propensity score survival evaluation, European Journal of Surgical Oncology (EJSO), vol.43, issue.2, 2016.
DOI : 10.1016/j.ejso.2016.09.011

S. Reddy, T. Pawlik, and D. Zorzi, Simultaneous Resections of Colorectal Cancer and Synchronous Liver Metastases: A Multi-institutional Analysis, Annals of Surgical Oncology, vol.129, issue.12, pp.3481-91, 2007.
DOI : 10.1245/s10434-007-9522-5

K. Tanaka, H. Shimada, and K. Matsuo, Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases, Surgery, vol.136, issue.3, pp.650-659, 2004.
DOI : 10.1016/j.surg.2004.02.012

A. Thelen, S. Jonas, and C. Benckert, Simultaneous versus staged liver resection of synchronous liver metastases from colorectal cancer, International Journal of Colorectal Disease, vol.19, issue.10, pp.1269-76, 2007.
DOI : 10.1007/s00384-007-0286-y

R. De-haas, R. Adam, and D. Wicherts, Comparison of simultaneous or delayed liver surgery for limited synchronous colorectal metastases, British Journal of Surgery, vol.14, issue.8, pp.1279-89, 2010.
DOI : 10.1007/978-3-642-51873-7

S. Liu, J. Church, I. Lavery, and V. Fazio, Operation in patients with incurable colon cancer???Is it worthwhile?, Diseases of the Colon & Rectum, vol.40, issue.1, pp.11-15, 1997.
DOI : 10.1007/BF02055675

L. Kuo, S. Leu, and M. Liu, How aggressive should we be in patients with stage iv colorectal cancer?, Diseases of the Colon & Rectum, vol.46, issue.12, pp.1646-52, 2003.
DOI : 10.1007/BF02660770

S. Rosen, J. Buell, and A. Yoshida, Initial Presentation With Stage IV Colorectal Cancer, Archives of Surgery, vol.135, issue.5, pp.530-534, 2000.
DOI : 10.1001/archsurg.135.5.530

URL : http://archsurg.jamanetwork.com/data/journals/surg/9430/sws9020.pdf

G. Mentha, P. Majno, and A. Andres, Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary, British Journal of Surgery, vol.231, issue.7, pp.872-880, 2006.
DOI : 10.1002/bjs.5346

A. Andres, C. Toso, and R. Adam, A Survival Analysis of the Liver-First Reversed Management of Advanced Simultaneous Colorectal Liver Metastases, Annals of Surgery, vol.256, issue.5, pp.772-780, 2012.
DOI : 10.1097/SLA.0b013e3182734423

A. Brouquet, M. Mortenson, and J. Vauthey, Surgical Strategies for Synchronous Colorectal Liver Metastases in 156 Consecutive Patients: Classic, Combined or Reverse Strategy?, Journal of the American College of Surgeons, vol.210, issue.6, pp.934-975, 2010.
DOI : 10.1016/j.jamcollsurg.2010.02.039

S. Mayo, C. Pulitano, and H. Marques, Surgical Management of Patients with Synchronous Colorectal Liver Metastasis: A Multicenter International Analysis, Journal of the American College of Surgeons, vol.216, issue.4, pp.707-723, 2013.
DOI : 10.1016/j.jamcollsurg.2012.12.029

M. Okuno, E. Hatano, and Y. Kasai, Feasibility of the liver-first approach for patients with initially unresectable and not optimally resectable synchronous colorectal liver metastases, Surgery Today, vol.19, issue.6, 2015.
DOI : 10.1245/s10434-011-2061-0

K. Tanaka, T. Murakami, and K. Matsuo, Preliminary Results of ???Liver-First' Reverse Management for Advanced and Aggressive Synchronous Colorectal Liver Metastases: A Propensity-Matched Analysis, Digestive Surgery, vol.32, issue.1, pp.16-22, 2015.
DOI : 10.1159/000370253

F. Welsh, K. Chandrakumaran, and T. John, Propensity score-matched outcomes analysis of the liver-first approach for synchronous colorectal liver metastases, British Journal of Surgery, vol.96, issue.5, pp.600-606, 2016.
DOI : 10.1038/sj.bjc.6603670

D. Hanahan and R. Weinberg, The Hallmarks of Cancer, Cell, vol.100, issue.1, pp.57-70, 2000.
DOI : 10.1016/S0092-8674(00)81683-9

D. Hanahan and R. Weinberg, Hallmarks of Cancer: The Next Generation, Cell, vol.144, issue.5, pp.646-74, 2011.
DOI : 10.1016/j.cell.2011.02.013

C. Lim, C. Eveno, and M. Pocard, [Microenvironment and colorectal liver metastases angiogenesis: surgical implications], Bull Cancer, vol.100, issue.4, pp.343-50, 2013.
URL : https://hal.archives-ouvertes.fr/tel-01784875

R. Kaplan, R. Riba, and S. Zacharoulis, VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche Angiogenesis in synchronous and metachronous colorectal liver metastases: the liver as a permissive soil, Nature Ann Surg, vol.438, issue.2551, pp.820-786, 2005.

G. Mundy, Metastasis: Metastasis to bone: causes, consequences and therapeutic opportunities, Nature Reviews Cancer, vol.2, issue.8, pp.584-93, 2002.
DOI : 10.1038/nrc867

G. Bergers and L. Benjamin, Angiogenesis: Tumorigenesis and the angiogenic switch, Nature Reviews Cancer, vol.3, issue.6, pp.401-411, 2003.
DOI : 10.1038/nrc1093

R. Warren, H. Yuan, and M. Matli, Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis., Journal of Clinical Investigation, vol.95, issue.4, pp.1789-97, 1995.
DOI : 10.1172/JCI117857

S. Ishigami, S. Arii, and M. Furutani, Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer, British Journal of Cancer, vol.78, issue.10, pp.1379-84, 1998.
DOI : 10.1038/bjc.1998.688

P. Carmeliet, VEGF as a Key Mediator of Angiogenesis in Cancer, Oncology, vol.45, issue.3, pp.4-10, 2005.
DOI : 10.1038/nm988

N. Ferrara, VEGF as a Therapeutic Target in Cancer, Oncology, vol.288, issue.3, pp.11-17, 2005.
DOI : 10.1056/NEJMoa032691

Y. Takahashi, S. Tucker, and Y. Kitadai, Vessel Counts and Expression of Vascular Endothelial Growth Factor as Prognostic Factors in Node-Negative Colon Cancer, Archives of Surgery, vol.132, issue.5, pp.541-547, 1997.
DOI : 10.1001/archsurg.1997.01430290087018

T. Tokunaga, Y. Oshika, and Y. Abe, Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer, British Journal of Cancer, vol.77, issue.6, pp.998-1002, 1998.
DOI : 10.1038/bjc.1998.164

T. Zhang, T. Otevrel, and Z. Gao, Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer, Cancer Res, vol.61, issue.24, pp.8664-8671, 2001.

H. Seno, M. Oshima, and T. Ishikawa, Cyclooxygenase 2-and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps, Cancer Res, vol.62, issue.2, pp.506-517, 2002.

F. Okada, J. Rak, and B. Croix, Impact of oncogenes in tumor angiogenesis: Mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells, Proceedings of the National Academy of Sciences, vol.18, issue.1, pp.3609-3623, 1998.
DOI : 10.1128/MCB.18.1.85

H. Choi, M. Hyun, and G. Jung, Tumor Angiogenesis as a Prognostic Predictor in Colorectal Carcinoma with Special Reference to Mode of Metastasis and Recurrence, Oncology, vol.55, issue.6, pp.575-81, 1998.
DOI : 10.1159/000011915

R. Frank, T. Saclarides, and S. Leurgans, Tumor Angiogenesis as a Predictor of Recurrence and Survival in Patients with Node-Negative Colon Cancer, Annals of Surgery, vol.222, issue.6, pp.695-704, 1995.
DOI : 10.1097/00000658-199512000-00002

S. Tomisaki, S. Ohno, and Y. Ichiyoshi, Microvessel quantification and its possible relation with liver metastasis in colorectal cancer, Cancer, vol.43, issue.8, pp.1722-1730, 1996.
DOI : 10.1136/jcp.43.9.752

C. Fuchs, J. Marshall, and J. Barrueco, Randomized, Controlled Trial of Irinotecan Plus Infusional, Bolus, or Oral Fluoropyrimidines in First-Line Treatment of Metastatic Colorectal Cancer: Updated Results From the BICC-C Study, Journal of Clinical Oncology, vol.26, issue.4, pp.689-90, 2008.
DOI : 10.1200/JCO.2007.15.5390

H. Hurwitz, L. Fehrenbacher, and J. Hainsworth, Bevacizumab in Combination With Fluorouracil and Leucovorin: An Active Regimen for First-Line Metastatic Colorectal Cancer, Journal of Clinical Oncology, vol.23, issue.15, pp.3502-3510, 2005.
DOI : 10.1200/JCO.2005.10.017

F. Kabbinavar, J. Hambleton, and R. Mass, Combined Analysis of Efficacy: The Addition of Bevacizumab to Fluorouracil/Leucovorin Improves Survival for Patients With Metastatic Colorectal Cancer, Journal of Clinical Oncology, vol.23, issue.16, pp.3706-3718, 2005.
DOI : 10.1200/JCO.2005.00.232

F. Kabbinavar, J. Schulz, and M. Mccleod, Addition of Bevacizumab to Bolus Fluorouracil and Leucovorin in First-Line Metastatic Colorectal Cancer: Results of a Randomized Phase II Trial, Journal of Clinical Oncology, vol.23, issue.16, pp.3697-705, 2005.
DOI : 10.1200/JCO.2005.05.112

L. Saltz, S. Clarke, and E. Diaz-rubio, Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study, Journal of Clinical Oncology, vol.26, issue.12, pp.2013-2022, 2008.
DOI : 10.1200/JCO.2007.14.9930

J. Joyce and J. Pollard, Microenvironmental regulation of metastasis, Nature Reviews Cancer, vol.19, issue.4, pp.239-52, 2009.
DOI : 10.1053/sonc.2002.37263

T. Asahara, H. Masuda, and T. Takahashi, Bone Marrow Origin of Endothelial Progenitor Cells Responsible for Postnatal Vasculogenesis in Physiological and Pathological Neovascularization, Circulation Research, vol.85, issue.3, pp.221-229, 1999.
DOI : 10.1161/01.RES.85.3.221

T. Takahashi, C. Kalka, and H. Masuda, Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization, Nature Medicine, vol.121, issue.4, pp.434-442, 1999.
DOI : 10.1161/01.RES.83.3.233

D. Lyden, K. Hattori, and S. Dias, Impaired recruitment of bone-marrow???derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth, Nature Medicine, vol.88, issue.11, pp.1194-201, 2001.
DOI : 10.1161/01.RES.88.2.167

S. Rafii, D. Lyden, and R. Benezra, Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?, Nature Reviews Cancer, vol.91, issue.11, pp.826-861, 2002.
DOI : 10.1161/01.RES.0000026420.22406.79

W. Hilbe, S. Dirnhofer, and F. Oberwasserlechner, CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer, Journal of Clinical Pathology, vol.57, issue.9, pp.965-974, 2004.
DOI : 10.1136/jcp.2004.016444

Y. Lin, D. Weisdorf, A. Solovey, and R. Hebbel, Origins of circulating endothelial cells and endothelial outgrowth from blood, Journal of Clinical Investigation, vol.105, issue.1, pp.71-78, 2000.
DOI : 10.1172/JCI8071

P. Goon, G. Lip, and C. Boos, Circulating Endothelial Cells, Endothelial Progenitor Cells, and Endothelial Microparticles in Cancer, Neoplasia, vol.8, issue.2, pp.79-88, 2006.
DOI : 10.1593/neo.05592

R. Naik, J. D. Chuang, and E. , Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer, Breast Cancer Research and Treatment, vol.66, issue.3, pp.133-141, 2008.
DOI : 10.1161/01.RES.88.2.167

C. Richter-ehrenstein, J. Rentzsch, and S. Runkel, Endothelial progenitor cells in breast cancer patients, Breast Cancer Research and Treatment, vol.2, issue.3, pp.343-352, 2007.
DOI : 10.1161/01.RES.88.2.167

S. Matsusaka, M. Suenaga, and Y. Mishima, Circulating endothelial cells predict for response to bevacizumab-based chemotherapy in metastatic colorectal cancer, Cancer Chemotherapy and Pharmacology, vol.15, issue.3, pp.763-771, 2010.
DOI : 10.1158/1078-0432.CCR-09-1493

D. Malka, V. Boige, and N. Jacques, Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumab ???, Annals of Oncology, vol.27, issue.5, pp.919-946, 2011.
DOI : 10.1200/JCO.2008.20.2879

C. Massard, I. Borget, L. Deley, and M. , Prognostic value of circulating VEGFR2+ bone marrow-derived progenitor cells in patients with advanced cancer, European Journal of Cancer, vol.48, issue.9, pp.1354-62, 2012.
DOI : 10.1016/j.ejca.2012.01.021

F. Farace and J. Bidart, Circulating endothelial cells: biomarkers for monitoring activity of antiangiogenic therapy], Bull Cancer, vol.94, pp.254-263, 2007.

F. Bertolini, Y. Shaked, P. Mancuso, and R. Kerbel, The multifaceted circulating endothelial cell in cancer: towards marker and target identification, Nature Reviews Cancer, vol.438, issue.Suppl. 16, pp.835-880, 2006.
DOI : 10.1038/nature04186

R. Kaplan, S. Rafii, and D. Lyden, Preparing the "Soil": The Premetastatic Niche, Cancer Research, vol.66, issue.23, pp.11089-93, 2006.
DOI : 10.1158/0008-5472.CAN-06-2407

B. Psaila and D. Lyden, The metastatic niche: adapting the foreign soil, Nature Reviews Cancer, vol.3, issue.4, pp.285-93, 2009.
DOI : 10.4161/cc.5.11.2775

S. Hiratsuka, K. Nakamura, and S. Iwai, MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis, Cancer Cell, vol.2, issue.4, pp.289-300, 2002.
DOI : 10.1016/S1535-6108(02)00153-8

S. Hiratsuka, A. Watanabe, and Y. Sakurai, The S100A8???serum amyloid A3???TLR4 paracrine cascade establishes a pre-metastatic phase, Nature Cell Biology, vol.17, issue.11, pp.1349-55, 2008.
DOI : 10.1161/01.ATV.17.8.1599

N. Weidner, J. Semple, W. Welch, and J. Folkman, Tumor Angiogenesis and Metastasis ??? Correlation in Invasive Breast Carcinoma, New England Journal of Medicine, vol.324, issue.1, pp.1-8, 1991.
DOI : 10.1056/NEJM199101033240101

S. Fox, A. Moghaddam, and M. Westwood, Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: An immunohistochemical study, The Journal of Pathology, vol.548, issue.2, pp.183-90, 1995.
DOI : 10.1007/978-1-4613-2449-2_31

G. Landini, R. Katz, and D. Johnston, Quantitative analysis of the epithelial lining architecture in radicular cysts and odontogenic keratocysts Comparison of quantification of histochemical staining by hue-saturation-intensity (HSI) transformation and color-deconvolution, Head Face Med, vol.2, 2006.

G. Landini and I. Othman, Architectural analysis of oral cancer, dysplastic, and normal epithelia, Cytometry, vol.194, issue.1, pp.45-55, 2004.
DOI : 10.1007/978-3-0348-8501-0_17

T. Asahara, T. Murohara, and A. Sullivan, Isolation of Putative Progenitor Endothelial Cells for Angiogenesis, Science, vol.149, issue.5302, pp.964-971, 1997.
DOI : 10.1016/0006-291X(91)91276-I

E. Elsheikh, M. Uzunel, and Z. He, Only a specific subset of human peripheral-blood monocytes has endothelial-like functional capacity, Blood, vol.106, issue.7, pp.2347-55, 2005.
DOI : 10.1182/blood-2005-04-1407

J. Hur, C. Yoon, and H. Kim, Characterization of Two Types of Endothelial Progenitor Cells and Their Different Contributions to Neovasculogenesis, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.24, issue.2, pp.288-93, 2004.
DOI : 10.1161/01.ATV.0000114236.77009.06

D. Ingram, L. Mead, and H. Tanaka, Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood, Blood, vol.104, issue.9, pp.2752-60, 2004.
DOI : 10.1182/blood-2004-04-1396

J. Rehman, J. Li, C. Orschell, and K. March, Peripheral Blood "Endothelial Progenitor Cells" Are Derived From Monocyte/Macrophages and Secrete Angiogenic Growth Factors, Circulation, vol.107, issue.8, pp.1164-1173, 2003.
DOI : 10.1161/01.CIR.0000058702.69484.A0

URL : http://circ.ahajournals.org/content/circulationaha/107/8/1164.full.pdf

C. Urbich, C. Heeschen, and A. Aicher, Relevance of Monocytic Features for Neovascularization Capacity of Circulating Endothelial Progenitor Cells, Circulation, vol.108, issue.20, pp.2511-2517, 2003.
DOI : 10.1161/01.CIR.0000096483.29777.50

M. Yoder, L. Mead, and D. Prater, Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals, Blood, vol.109, issue.5, pp.1801-1810, 2007.
DOI : 10.1182/blood-2006-08-043471

S. Bruin, C. Klijn, and G. Liefers, Specific genomic aberrations in primary colorectal cancer are associated with liver metastases, BMC Cancer, vol.6, issue.1, pp.662-73195, 2008.
DOI : 10.1016/j.cancergencyto.2005.12.011

F. Bertolini, S. Paul, and P. Mancuso, Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells, Cancer Res, vol.63, issue.15, pp.4342-4348, 2003.

Y. Shaked, F. Bertolini, and S. Man, Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis, Cancer Cell, vol.7, issue.1, pp.101-112, 2005.

K. Man, K. Ng, and C. Lo, Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases???Activation of cell invasion and migration pathways, Liver Transplantation, vol.160, issue.12, pp.1669-77, 2007.
DOI : 10.1016/S0039-6060(98)70075-3

I. Nicoud, C. Jones, and J. Pierce, Warm Hepatic Ischemia-Reperfusion Promotes Growth of Colorectal Carcinoma Micrometastases in Mouse Liver via Matrix Metalloproteinase-9 Induction, Cancer Research, vol.67, issue.6, pp.2720-2728, 2007.
DOI : 10.1158/0008-5472.CAN-06-3923

M. Nijkamp, F. Hoogwater, and E. Steller, CD95 is a key mediator of invasion and accelerated outgrowth of mouse colorectal liver metastases following radiofrequency ablation Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model Perinecrotic hypoxia contributes to ischemia/reperfusion-accelerated outgrowth of colorectal micrometastases, J Hepatol Hepatology Am J Pathol, vol.53, issue.1704, pp.1069-77165, 2005.

F. Giuliante, F. Ardito, and C. Pulitano, Does Hepatic Pedicle Clamping Affect Disease-Free Survival Following Liver Resection for Colorectal Metastases?, Annals of Surgery, vol.252, issue.6, pp.1020-1026, 2010.
DOI : 10.1097/SLA.0b013e3181f66918

M. Weiss, H. Ito, and R. Araujo, Hepatic Pedicle Clamping During Hepatic Resection for Colorectal Liver Metastases: No Impact on Survival or Hepatic Recurrence, Annals of Surgical Oncology, vol.238, issue.6, pp.285-94, 2012.
DOI : 10.1097/01.sla.0000098620.27623.7d